Full-Time

Sr. Associate: Labelling

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • Doctorate degree OR
  • Master’s degree and 2 to 4 years of directly related experience OR
  • Bachelor’s degree and 4 to 6 years of directly related experience OR
  • Diploma and 8 to 10 years of directly related experience
  • Equivalent combinations of education and experience may be considered.
Responsibilities
  • Coordinate day-to-day labeling activities, ensuring timely updates and compliance with global regulatory requirements.
  • Serve as a key contact for cross-functional teams, providing operational support and guidance on labeling procedures, formats, and timelines.
  • Execute labeling change requests, track progress, and maintain accurate documentation in labeling management systems.
  • Collaborate with global and regional stakeholders (Regulatory Affairs, Quality, Operations, Supply Chain) to streamline labeling processes and ensure alignment across multiple time zones.
  • Identify and escalate potential compliance risks or delays in labeling updates, partnering with relevant teams to resolve issues efficiently.
  • Proactively engage with global affiliates to gather requirements, clarify expectations, and facilitate smooth implementation of labeling changes.
  • Contribute to continuous improvement initiatives, optimizing labeling processes, templates, and workflows to enhance efficiency and compliance.
  • Support the maintenance of inspection readiness by ensuring that documentation, SOPs, and labeling processes adhere to quality standards and internal policies.
  • Collect and analyze data on labeling operations, recommending improvements to enhance transparency, speed, and accuracy.
  • Collaborate with vendors involved in labeling activities (e.g., translation services, artwork vendors) to ensure they meet quality and timeline requirements.
  • Assist in monitoring vendor performance against established SLAs, promptly highlighting any gaps or issues to internal partners.
  • Participate in regular meetings with internal and external partners to align on project deliverables, address operational challenges, and drive timely completion of milestones.
  • Provide guidance and operational support to junior staff and peers on labeling compliance processes, best practices, and quality standards.
  • Help develop or refine training materials and job aids, promoting consistent understanding and application of labeling procedures across teams.
  • Stay updated on emerging regulatory requirements and industry trends, sharing insights that could impact labeling strategies and practices.
Desired Qualifications
  • Experience working with labeling management systems (e.g., Veeva Vault) or other document management platforms.
  • Familiarity with global labeling regulations and end-to-end labeling processes.
  • Demonstrated ability to plan and manage projects in a matrix organization, meeting deadlines and handling multiple tasks effectively.
  • Strong collaboration and communication skills, comfortable working with international teams across time zones.
  • Proven problem-solving capabilities, with an analytical mindset and attention to detail.
  • Experience in vendor coordination, ensuring quality and compliance with established metrics.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.